Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies

Thumbnail Image
Download
Name

s43856-021-00045-9.pdf

Description
Published version
Size

2.06 MB

Format

Adobe PDF

Checksum (MD5)

17bac0de4385281d4d0ea5783f67fe03

sword-2025-12-15T21:28:00.original.xml (130 B)
Original SWORD entry document
Author(s)
Kongsuphol, Patthara
•
Jia, Huan
•
Cheng, Hoi Lok
•
Gu, Yue
•
Shunmuganathan, Bhuvaneshwari DO
•
Chen, Ming Wei
•
Lim, Sing Mei
•
Ng, Say Yong
•
Tambyah, Paul Ananth
•
Nasir, Haziq
more
Date Issued
November 11, 2021
Journal
Communications Medicine
Publisher
Springer Science and Business Media LLC
Citation
Kongsuphol, P., Jia, H., Cheng, H.L. et al. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies. Commun Med 1, 46 (2021).
Version
Final published version
Abstract
Background Neutralizing antibodies (NAbs) prevent pathogens from infecting host cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor vaccine efficacy against SARS-CoV-2, the virus that causes COVID-19. All currently available NAb tests are lab-based and time-intensive. Method We develop a 10 min cellulose pull-down test to detect NAbs against SARS-CoV-2 from human plasma. The test evaluates the ability of antibodies to disrupt ACE2 receptor— RBD complex formation. The simple, portable, and rapid testing process relies on two key technologies: (i) the vertical-flow paper-based assay format and (ii) the rapid interaction of cellulose binding domain to cellulose paper. Results Here we show the construction of a cellulose-based vertical-flow test. The developed test gives above 80% sensitivity and specificity and up to 93% accuracy as compared to two current lab-based methods using COVID-19 convalescent plasma. Conclusions A rapid 10 min cellulose based test has been developed for detection of NAb against SARS-CoV-2. The test demonstrates comparable performance to the lab-based tests and can be used at Point-of-Care. Importantly, the approach used for this test can be easily extended to test RBD variants or to evaluate NAbs against other pathogens.
MIT Department
Singapore-MIT Alliance in Research and Technology (SMART)
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Creative Commons Attribution
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/164328
DOI of Published Version
https://doi.org/10.1038/s43856-021-00045-9
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.